The results showed that the downstream targets by the TFs were significantly enriched in a few critical cancer-related pathways, such as PI3K-Akt signaling pathway, cell cycle, FoxO signaling pathway, small cell lung cancer, p53 signaling pathway (Fig. 7F, Supplementary excel 5). This evidence concerns the gene AKT1 and small cell lung carcinoma.